Weaver Consulting Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Weaver Consulting Group's LLY Position: Q1 2026 in Review
Weaver Consulting Group reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $8.11K and leaving 518 shares worth $476K. The position accounts for 0.11% of the portfolio, ranked #153.
Weaver Consulting Group first reported a position in LLY in Q1 2019 and has held it in 25 quarters since. The position peaked at $565K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Weaver Consulting Group held 518 shares of Eli Lilly worth $476K as of Q1 2026.
- Weaver Consulting Group sold 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
- Eli Lilly made up 0.11% of Weaver Consulting Group's portfolio in Q1 2026, its #153 holding.
- Weaver Consulting Group first reported a position in Eli Lilly in Q1 2019 and has held it in 25 quarters since.
- Weaver Consulting Group's Eli Lilly position peaked at $565K in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Weaver Consulting Group's 13F filing for Q1 2026, filed 15 May 2026.